Kidney transplantation;Greffe de rein

Revue du Praticien

Volumn 57, Issue 3, 2007, Pages 269-279

  Hiesse, Christian ^a  

^a Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ECONOMIC ASPECT; HEALTH CARE COST; HEMODIALYSIS; HOSPITALIZATION COST; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MASS SCREENING; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33847342987     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Lysaght MJ. Maintenance dialysis population dynamics : current trends and long-term implications. J Am Soc Nephrol 2002;13:S37-S40.
2. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-9.
3. United States Renal Data system. Annual Report 2006. http://www.usrds.org
4. Réseau épidémiologie information en néphrologie (REIN). Rapport annuel 2005. http://www.agence- biomedecine.fr
5. Macron-Noguès F, Vernay M, Ekong E, et al. La prévalence de l'insuffisance rénale chronique terminale traitée par dialyse en France en 2003 : l'enquête nationale SROS-IRCT. BEH 2005;37/38:182-4.
6. Halimi S, Zmirou D, Benhamou PY, et al. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study). Diabetes Metab 1999;25:507-12.
7. th century. N Engl J Med 2004;351:2678-80.
8. Neipp M, Karavul B, Jackobs S, et al. Quality of life in adult recipients more than 15 years after kidney transplantation. Transplantation 2006;81:1640-4.
9. Matesanz R, Miranda B. A decade of continuous improvement in cadaveric organ donation: the Spanish model. J Nephrol 2002;15:22-8.
10. Organizacion Nacional de Transplantes. Memoria de la actividad de donacion y trasplante. http://www.ont.es
11. Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation 2000;70:755-60.
12. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;34:11725-30.
13. Ojo AO, Hanson JA, Meier-Kriesche HU, et al. Survival in recipients of marginal cadaveric donor kidneys compared with older recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001;12:589-97.
14. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004;4:1662-8.
15. Oniscu GC, Brown H, Forsythe JL. How old is old for transplantation. Am J Transplant 2004;4:2067-74.
16. EPBG, Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation (Part 1). Nephrol Dial Transplant 2000;15:1-85.
17. Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001;71:1189-204.
18. Oniscu GC, Schalkwijk AH, Johnson RJ, Brown H, Forsythe JLR. Equity to access to renal transplant waiting list and renal transplantation in Scotland: cohort study. BMJ 2003;327:1261-8.
19. Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation 2006;81:1658-61.
20. Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 1997;2:14-7.
21. Agence de la biomédecine. Rapport annuel 2005. http://www.agence-biomedecine.fr
22. The U.S. organ procurement and transplantation network and the scientific registry of transplant recipients. 2005 OPTN / SRTR Annual Report. http://www.optn.org
23. Hiesse C, Pessione F, Houssin S. The case to abandon human leukocyte antigen matching for kidney allocation: would it be wise to throw out the baby with the bathwater? Transplantation 2004;77:623-6.
24. Roberts JP, Wolfe RA, Bragg-Gresham JL. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med 2004;350:545-51.
25. Cantrelle C, Laurens C, Loty B, Tuppin P. Access to kidney transplantation of non-French patients and French patients living in overseas territories. Transplantation 2006;81:1147-52.
26. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000;58:1311-7.
27. WHO. Global knowledge base on transplantation (GKT). http://www.who.int/topics/transplantation/en/
28. Mange KF, Joffe MM, Feldman HI. Effect of the use or non use of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001;344:726-31.
29. Gjertson DW. Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002.Clin Transpl 2003:337-86.
30. Meier-Kriesche HU, Li S, Gruessner LW, et al. Immunosuppression: evolution in practice and trends. Am J Transplant 2006;6:1113-31.
31. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-23.
32. Pessione F, Cohen S, Durand D, et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2002;75:361-7.
33. Cohen B, Smits JM, Haase B, et al. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005;20:34-41.
34. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006;354:342-52.
35. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric transplant recipients independent of acute rejection. Transplantation 1998;66:266-74.
36. Meier-Kriesche HU, Schold JD, Kaplan B, et al. Long-term allograft survival: Have we made significant progress or it is the time to rethink our analytic and therapeutic strategies? Am J Transplant 2004;4:1289-95.
37. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concern and future directions. Transplantation 2006;81:643-54.
38. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006;82:603-11.
39. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90.